Raymond James & Associates Inovio Pharmaceuticals, Inc. Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 16, 2024	SELL	$0.35 - $0.53 $1,750 - $2,650	-5,000 Reduced 32.3%	10,480 $5,000
Q3 2023 Oct 24, 2023	BUY	$0.38 - $0.58 $76 - $115	200 Added 1.31%	15,480 $6,000
Q2 2023 Jul 25, 2023	SELL	$0.39 - $0.94 $308 - $743	-791 Reduced 4.92%	15,280 $6,000
Q1 2023 Apr 14, 2023	BUY	$0.79 - $1.91 $609 - $1,472	771 Added 5.04%	16,071 $13,000
Q4 2022 Feb 08, 2023	SELL	$1.41 - $2.5 $5,438 - $9,642	-3,857 Reduced 20.13%	15,300 $23,000
Q3 2022 Oct 25, 2022	SELL	$1.66 - $2.79 $15,627 - $26,265	-9,414 Reduced 32.95%	19,157 $33,000
Q2 2022 Aug 12, 2022	BUY	$1.44 - $3.98 $144 - $398	100 Added 0.35%	28,571 $49,000
Q1 2022 May 11, 2022	SELL	$2.97 - $5.2 $7,929 - $13,884	-2,670 Reduced 8.57%	28,471 $102,000
Q4 2021 Feb 08, 2022	SELL	$4.99 - $7.46 $3,892 - $5,818	-780 Reduced 2.44%	31,141 $155,000
Q3 2021 Nov 02, 2021	BUY	$7.16 - $9.69 $66,638 - $90,184	9,307 Added 41.16%	31,921 $229,000
Q2 2021 Aug 11, 2021	SELL	$6.23 - $10.03 $6,921 - $11,143	-1,111 Reduced 4.68%	22,614 $210,000
Q1 2021 May 14, 2021	SELL	$8.81 - $16.96 $58,436 - $112,495	-6,633 Reduced 21.85%	23,725 $220,000
Q4 2020 Feb 12, 2021	BUY	$8.5 - $12.85 $1,938 - $2,929	228 Added 0.76%	30,358 $269,000
Q3 2020 Nov 04, 2020	BUY	$9.57 - $27.05 $52,644 - $148,802	5,501 Added 22.34%	30,130 $350,000
Q2 2020 Jul 28, 2020	BUY	$7.14 - $31.69 $17,642 - $78,305	2,471 Added 11.15%	24,629 $664,000
Q1 2020 Apr 21, 2020	SELL	$2.98 - $14.09 $14 - $70	-5 Reduced 0.02%	22,158 $165,000
Q4 2019 Feb 12, 2020	BUY	$1.97 - $3.72 $8,027 - $15,159	4,075 Added 22.53%	22,163 $73,000
Q3 2019 Nov 07, 2019	BUY	$2.05 - $3.02 $5,153 - $7,592	2,514 Added 16.14%	18,088 $37,000
Q1 2019 May 06, 2019	SELL	$3.34 - $5.1 $32,802 - $50,087	-9,821 Reduced 38.67%	15,574 $58,000
Q4 2018 Feb 11, 2019	BUY	$3.89 - $6.11 $54,389 - $85,430	13,982 Added 122.51%	25,395 $102,000
Q3 2018 Nov 14, 2018	BUY	$3.92 - $5.58 $44,738 - $63,684	11,413 New	11,413 $63,000

Others Institutions Holding INO

# of Institutions

Shares Held

281K

Call Options Held

Put Options Held

View Full List

About INOVIO PHARMACEUTICALS, INC.

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $456M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

More about INO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account